- Report
- May 2022
- 231 Pages
Global
From €4669EUR$4,799USD£4,000GBP
- Report
- May 2022
- 365 Pages
Global
From €4669EUR$4,799USD£4,000GBP
- Report
- April 2020
- 248 Pages
Global
From €4767EUR$4,899USD£4,083GBP
- Report
- October 2022
- 194 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- August 2021
- 113 Pages
Global
From €2676EUR$2,750USD£2,292GBP
€5351EUR$5,500USD£4,584GBP
- Report
- April 2020
- 108 Pages
Global
From €934EUR$960USD£800GBP
€1168EUR$1,200USD£1,000GBP
- Report
- April 2023
- 150 Pages
Global
From €4719EUR$4,850USD£4,043GBP
- Report
- March 2021
- 229 Pages
Global
From €4062EUR$4,175USD£3,480GBP
- Report
- March 2023
- 143 Pages
Global
From €2431EUR$2,499USD£2,083GBP
- Report
- October 2020
- 38 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- May 2019
- 60 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- April 2019
- 73 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- June 2021
- 32 Pages
Global
€21406EUR$22,000USD£18,337GBP
- Drug Pipelines
- January 2018
- 10 Pages
Global
From €9730EUR$10,000USD£8,335GBP
- Drug Pipelines
- January 2018
- 13 Pages
Global
From €9730EUR$10,000USD£8,335GBP
- Report
- September 2019
- 12 Pages
Global
€9730EUR$10,000USD£8,335GBP
- Report
- November 2019
- 153 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- June 2023
- 326 Pages
China
From €3892EUR$4,000USD£3,334GBP
- Report
- June 2023
- 90 Pages
China
From €1751EUR$1,800USD£1,500GBP
- Report
- October 2018
- 21 Pages
Global
From €9730EUR$10,000USD£8,335GBP
The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more
